Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Intensive Therapy Associated With CSII on β-cell Function With Newly Diagnosed Type 2 Diabetes

NCT00948324 is registered in ClinicalTrials.gov with Sun Yat-sen University as lead sponsor.

NCT NCT00948324
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00948324 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Intensive Therapy Associated With CSII on β-cell Function With Newly Diagnosed Type 2 Diabetes
Lead sponsor
Sun Yat-sen University
Phase
Phase 4
Overall status
Suspended
Start date
June 30, 2008
Completion date
December 31, 2021
Enrollment
400 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes mellitus